EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
DOI: 10.1016/j.ard.2026.01.023
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0003496726000750
其他信息:
出版社: Elsevier BV
作者: Josef S. Smolen; Christopher J. Edwards; Victoria Konzett; Faidra Laskou; Daniel Aletaha; Roberto Caporali; Thomas Dörner; Kimme L. Hyrich; Elsa Mateus; Janet E. Pope; Jette Primdahl; Savia de Souza; Tanja Stamm; Tsutomu Takeuchi; Désirée van der Heijde; Patrick Verschueren; Kevin L. Winthrop; Jose Maria Alvaro-Gracia; Johan Askling; Joan Bathon; Maya H. Buch; Gerd R. Burmester; Catalin Codreanu; Philip G. Conaghan; Maurizio Cutolo; Bruno Fautrel; Joao Fonseca; Laure Gossec; Espen Haavardsholm; Merete Lund Hetland; Annamaria Iagnocco; Pierre-Antonie Juge; Zhanguo Li; Rikke Helene Moe; Peter Nash; Gyula Poór; Andrea Rubbert-Roth; Raquel dos Santos Sobrin; Hendrik Schulze-Koops; Russka Shumnalieva; Ladislav Senolt; Lucia Silva-Fernandez; Anja Strangfeld; Peter Taylor; Carl Turesson; Elsa van Duuren; Maarten de Wit; Ricardo Xavier; Andreas Kerschbaumer; Robert B. M. Landewé
